Silvia Antolín - Concepedia

Author

Silvia Antolín

Complexo Hospitalario Universitario A Coruña ORCID

Also Known As

Begoña Jiménez Rodríguez, Blancas, Isabel, Bożena Kukielka-Budny, J. Cassinello, S Antolin, S Antolín, S Antolín-Novoa, S. Antolin, S. Antolin Novoa, S. Antolin-Novoa

167

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Complexo Hospitalario Universitario A Coruña GEICAM – Spanish Breast Cancer Group Hospital General Universitario Gregorio Marañón Fundación Instituto Valenciano de Oncología Centro de Investigación Biomédica en Red de Cáncer

About

Silvia Antolín is an author at Complexo Hospitalario Universitario A Coruña specializing in breast cancer, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1.3K
2	Health Sciences	7	7	900
3	Public Health	2	2	48
4	Nursing	1	1	20
5	Biostatistics	1	1	32

Silvia Antolín

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial Sara A. Hurvitz, Roberto Hegg, Wei‐Pang Chung, The Lancet Breast OncologyMedicineClinical TrialsPathologyBreast Cancer	2022	580
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study Erica L. Mayer, Amylou C. Dueck, Miguel Martín, The Lancet Oncology Interim AnalysisEndocrine OncologyBreast OncologyOncologyEarly Breast Cancer	2021	250
Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer Juan Miguel Cejalvo, Eduardo Martínez de Dueñas, Patricia Galván, Cancer Research	2017	239
Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy Ángela Santonja, Alfonso Sánchez‐Muñoz, Aňa Lluch, Oncotarget Lehmann Tnbc SubtypesBreast OncologyTumor HeterogeneityMedicinePathology	2018	182
Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case–control EpiGEICAM study Adela Castelló, Marina Pollán, Brian Buijsse, British Journal of Cancer	2014	179
Lower Breast Cancer Risk among Women following the World Cancer Research Fund and American Institute for Cancer Research Lifestyle Recommendations: EpiGEICAM Case-Control Study Adela Castelló, Miguel Martín, Ana Casas, PLoS ONE	2015	100
Circulating miR-200c and miR-141 and outcomes in patients with breast cancer Silvia Antolín, Lourdes Calvo, M. Blanco, BMC Cancer	2015	91
Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study Eduardo Martínez de Dueñas, Ana Lluch Hernández, Ángel Guerrero Zotano, Breast Cancer Research and Treatment	2014	65
A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012–12 (EDALINE) study Manuel Ruíz‐Borrego, Begoña Jiménez, Silvia Antolín, Investigational New Drugs Phase Ib StudyOncologyMedicineCancer Cell BiologyBreast Cancer	2018	54
Multicenter Phase II Study of Lurbinectedin in <i>BRCA</i>-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy Cristina Cruz, Alba Llop‐Guevara, Judy E. Garber, Journal of Clinical Oncology	2018	47

Page 1